On June 24, 2025, GSK plc purchased 476,537 shares at prices ranging from 1,403.50p to 1,421.50p as part of its ongoing buyback program, accumulating a total of 6,103,579 shares since June 4, 2025. The total shares issued, excluding treasury shares, are now 4,091,107,510 with treasury shares representing 5.48% of voting rights.